Anderson-Fabry病研究进展
被引量:4
摘要
Anderson-Fabry病(Anderson-Fabry Disease, AFD)又称为Fabry病,是X连锁隐性遗传的溶酶体病,患者因缺乏α-半乳糖苷酶A(α-Gal A),致使糖鞘脂成分如神经酰胺三己糖苷(CTH)或globotriaosylce-ramide(Gb3)、二乳糖苷神经酰胺等堆积于体内各器官,引起临床表现.
出处
《南京医科大学学报(自然科学版)》
CAS
CSCD
北大核心
2003年第6期642-645,共4页
Journal of Nanjing Medical University(Natural Sciences)
参考文献18
-
1Pastores GM, Lien YH. Biochemical and molecular genetic basis of Fabry disease [J] . J Am Soc Nephrol, 2002, 13(suppl 2) :S130-S133.
-
2Branton M, Schiffmann R, Kopp JB. Natural history and treatment of renal involvement in Fabry disease [J]. J Am Soc Nephrol,2002,13(suppl 2) :S139 - S143.
-
3Alroy J, Sabnis S, Kopp JB. Renal pathology in Fabry disease[J] . J Am Soc Nephrol, 2002, 13(suppl 2) : S134 -S138.
-
4Kampmann C, Baehner F, Ries M, et al. Cadiae involvement in Anderson-Fabry disease[J]. J Am Soc Nephrol,2002,13 (suppl 2) :S147 - S149.
-
5Kolodny EH, Pastores GM. Anderson-Fabry disease: extrarenal, neurologic manifestations[J]. J Am Soc Nephrol,2002,13 (suppl 2) :S150 - S153.
-
6MacDermot J, MacDermot KD. Neuropathie pain in Anderson-Fabry disease:pathology and therapeutic options[J].Eur J Pharmacol,2001,429:121 - 125.
-
7Moore DF, Scott LTC, Gladwin MT, et al. Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease [ J ]. Circulation, 2001,104 : 1506 - 1512.
-
8DeGraba T, Azhar S, Dignar-George F, et al. Profile of endothelial and leukocyte activation in Fabry patients [J].Ann Neurol, 2000,47:229 - 233.
-
9Ziegler R J, Yew NS, Li C, et al. Correction of enzymatic and lysosomal storage defects in Fabrv mice by aden-ovirus-mediated gene transfer[J]. Hum Gene Ther, 1999,10:1667 - 1682.
-
10Ohshima T, Schiffmann R, Murray GJ, et al. Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice[J]. Proc Natl Acad Sci USA, 1999,96:6423 - 6427.
同被引文献45
-
1郑晓刚,周晓军,张泰和,陆珍凤.Fabry氏病肾活检的电镜诊断[J].电子显微学报,1995,14(5):332-335. 被引量:1
-
2张静,刘彦仿,刘健,程虹,王汉民,崔继红,任丽君.Fabry肾病临床病理观察[J].诊断病理学杂志,2005,12(4):263-266. 被引量:8
-
3Sheu SS, Chan LP, Liao SC, et al. Fabry's disease: clinical, pathologic and biochemical manifestations in two chinese males. Zhonghua Yi Xue Za Zhi( Taipei ), 1994,54:368-372.
-
4Linthorst GE, Vedder AC, Aerts JM, et al. Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers. Clin Chim Acta,2005 ,353 :201-203.
-
5Masson C, Cisse I, Simon V, et al. Fabry disease: a review. Joint Bone Spine,2004,71:381-383.
-
6MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet,2001,38 :769-775.
-
7Hoffmann B, Beck M, Sunder-Plassmann G, et al. Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy-a retrospective analysis from the Fabry Out-come Survey. Clin J Pain,2007,23:535-542.
-
8Mehta A. New developments in the management of Anderson-Fabry disease. QJM, 2002,95 : 647 -653.
-
9Mac Dermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet,2001,38 :750-760.
-
10Bishop DF, Calhoun DH, Bemstein HS, et al. Human ot-galactosidase A : nucleotide sequence of a cDNA clone encoding the mature enzyme. Proe Natl Acad Sci USA, 1986,83:4859-4863.
引证文献4
-
1张静,刘彦仿,刘健,程虹,王汉民,崔继红,任丽君.Fabry肾病临床病理观察[J].诊断病理学杂志,2005,12(4):263-266. 被引量:8
-
2朱平,郝翠兰,田晔,易静,陈楠.Fabry病肾脏的超微病理研究[J].电子显微学报,2005,24(6):564-568. 被引量:2
-
3胡汉华,米娜娃尔.玉诺斯,谢风莲,汤建安,桑晓红.Fabry病肾活检病理观察[J].新疆医科大学学报,2006,29(3):202-203.
-
4王雯,蒋坚,陈晓丽,杨涛,周红文.一例Fabry病患者α-半乳糖苷酶基因突变和酶活性分析[J].中华内分泌代谢杂志,2010,26(1):27-31. 被引量:1
二级引证文献11
-
1胡建军,查月芳,苏庆录,李卫红,黄凌慧,张广宇.抗结核药物致大鼠肾脏损害电镜研究[J].河北医药,2009,31(21):2869-2871. 被引量:1
-
2胡汉华,米娜娃尔.玉诺斯,谢风莲,汤建安,桑晓红.Fabry病肾活检病理观察[J].新疆医科大学学报,2006,29(3):202-203.
-
3张明辉,刘艳辉,史伟,罗东兰,骆新兰,姚军,庄恒国.Fabry病肾病临床病理分析[J].临床与实验病理学杂志,2010,26(2):207-210. 被引量:6
-
4常毅娜,鞠现霞,崔琴,王坤林,周红文.α-半乳糖苷酶A活性检测对Fabry病筛查和诊断的意义[J].中华内分泌代谢杂志,2012,28(1):54-57. 被引量:3
-
5张莹,肖笑,熊轩,陈敏,胡建广,刘岩.以肾脏表现为首发症状的Fabry病1例报告及文献复习[J].中国中西医结合肾病杂志,2012,13(3):248-249. 被引量:4
-
6潘晓霞,欧阳彦,王朝晖,任红,沈平雁,史浩,王伟铭,徐耀文,倪莉燕,杨莉,徐静,纪永松,陈楠.法布里病83例临床病理特点分析[J].中国实用内科杂志,2014,34(3):262-266. 被引量:18
-
7纪永松,王展鹏,杜凯阳,程岚,石智勇,刘洪亮,李瑞.Fabry病二例肾脏病理表现及文献复习[J].中华临床医师杂志(电子版),2014,8(20):113-116. 被引量:2
-
8廖莹,何丽娟,陈洪滔,何永成.以肾脏病变为表现的Fabry病3例报告并文献复习[J].罕少疾病杂志,2015,22(3):36-37. 被引量:1
-
9赵飞,窦艳娜,赵占正.Fabry病的诊疗新进展[J].医学理论与实践,2016,29(13):1709-1711. 被引量:2
-
10陈虹秀,徐忠良,邢英琦,刘影.双侧颈动脉体瘤所致头痛1例报告[J].中风与神经疾病杂志,2018,35(7):652-653.
-
1陈楠.中国法布里病(Fabry病)诊治专家共识[J].中华医学杂志,2013,93(4):243-247. 被引量:55
-
2李宏建.Fabry病在原因不明性卒中患者中的患病率[J].国外医学(脑血管疾病分册),2005,13(12):937-937.
-
3薛素芳,宋晓微,武剑.α-半乳糖苷酶A缺乏病与青年缺血性卒中的研究进展[J].中国脑血管病杂志,2014,11(2):96-99. 被引量:2
-
4徐茂凯,孔德聪,郑玉玲,郝淮杰,姜永强.铜绿假单胞菌凝集素PA-ⅠL的纯化表达及活性评价[J].军事医学,2017,41(3):205-208.
-
5李文歌.Fabry病的肾脏病变及诊治进展[J].中国医师进修杂志(内科版),2006,29(6):8-10. 被引量:4
-
6李一,柳忠辉,杨贵贞.抗ACTH单克隆抗体制备及鉴定[J].白求恩医科大学学报,1993,19(1):103-104.
-
7杨月(编译).伯氏疏螺旋体可激活自然杀伤T细胞受体[J].传染病网络动态,2006(10):1-1.
-
8Rolfs A,Bttcher T,Zschiesche M.,桑延智.隐源性卒中患者中Fabry病的患病率:一项前瞻性研究[J].世界核心医学期刊文摘(眼科学分册),2006,2(3):9-10.
-
9徐莉娟,高红伟,季守平,宫锋,章扬培.重组人α-半乳糖苷酶A在巴氏毕赤酵母中的表达及鉴定[J].军事医学科学院院刊,2006,30(6):544-547.
-
10宋颖,柳曦光,李姝瑶.1例Fabry病的临床表现及电镜观察[J].中国麻风皮肤病杂志,2008,24(4):308-309.